财联社8月26日电,拓新药业公告,拟以不动产方式对精泉生物追加投资3010.6万元,投资金额全部计入精泉生物资本公积,公司仍持有精泉生物100%股权。
拓新药业-0.75%
财联社声明:文章内容仅供参考,不构成投资建议。投资者据此操作,风险自担。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.